Down-regulation of E-cadherin is the key target of epithelial to mesenchymal transition (EMT) modulators, which is known to dismantle cadherin-medicated cell–cell junctions and essential for embryonic development, cancer progression, and chemotherapy resistance [10,11]. This evidence concerns the gene CDH17 and cancer.